Clinical Trials Browser

OTHER × Ovarian Neoplasms × senaparib × Clear all

NCT07586449 2026-05-14

RESO

Not yet recruiting

Ovarian Neoplasms

NCT06617923 2025-10-27

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms